Log in to save to my catalogue

Is Intrapartum Intravenous Zidovudine for Prevention of Mother-to-Child HIV-1 Transmission Still Use...

Is Intrapartum Intravenous Zidovudine for Prevention of Mother-to-Child HIV-1 Transmission Still Use...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1428955665

Is Intrapartum Intravenous Zidovudine for Prevention of Mother-to-Child HIV-1 Transmission Still Useful in the Combination Antiretroviral Therapy Era?

About this item

Full title

Is Intrapartum Intravenous Zidovudine for Prevention of Mother-to-Child HIV-1 Transmission Still Useful in the Combination Antiretroviral Therapy Era?

Publisher

Oxford: Oxford University Press

Journal title

Clinical infectious diseases, 2013-09, Vol.57 (6), p.903-914

Language

English

Formats

Publication information

Publisher

Oxford: Oxford University Press

More information

Scope and Contents

Contents

Background. Intrapartum intravenous zidovudine (ZDV) prophylaxis is a long-standing component of prevention of mother-to-child transmission (MTCT) of human immunodeficiency virus (HIV) in high-resource countries. In some recent guidelines, intravenous ZDV is no longer systematically recommended for mothers receiving combination antiretroviral thera...

Alternative Titles

Full title

Is Intrapartum Intravenous Zidovudine for Prevention of Mother-to-Child HIV-1 Transmission Still Useful in the Combination Antiretroviral Therapy Era?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1428955665

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1428955665

Other Identifiers

ISSN

1058-4838

E-ISSN

1537-6591

DOI

10.1093/cid/cit374

How to access this item